The $400bn global Medical Products industry continues to see strong products innovation. This offer the hope for a sustainable mid-single digit top line growth over the long term. In-Vitro-Diagnostics (IVD), Cardiovascular devices, Orthopedics & Diagnostic Imaging remain the leading revenue contributors to the sector through 2022.